Lymph-Borne Melanoma-Derived Proteins as Determinants of Lymph Node Metastasis
淋巴源性黑色素瘤衍生蛋白作为淋巴结转移的决定因素
基本信息
- 批准号:10535107
- 负责人:
- 金额:$ 3.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AlbuminsAmino AcidsBehaviorBenignBiochemistryBiologyBloodBreastCSPG4 geneCancer BiologyCancer EtiologyCellsCessation of lifeChemicalsChondroitin Sulfate ProteoglycanCommunicationContralateralDataData AnalysesDependenceDermatologyDermisDevelopmentDistantDrainage procedureEducational process of instructingEventExhibitsFoundationsFutureGoalsGrowthHumanImmune responseImmunosuppressionIn VitroInstitutesInstitutionLabelLengthLungLymphLymphangiogenesisLymphatic Endothelial CellsLymphatic SystemMalignant NeoplasmsMediatingMedicineMelanoma CellMentorsMetastatic Neoplasm to Lymph NodesMetastatic toMethodsModernizationMolecularMusNeoplasm MetastasisOrganPathologyPatient riskPatientsPharmacologyPhenotypePhysiologicalPlayPopulationPre-Clinical ModelPrimary NeoplasmPrognosisPrognostic MarkerProteinsResearchResearch PersonnelRoleSeedsSerumSiteSoilSolid NeoplasmSourceStromal CellsSystemTechniquesTestingTherapeutic InterventionTissuesTrainingTumor EscapeTumor-DerivedTumor-Secreted ProteinWorkWritingcareerconditioningdata integrationdraining lymph nodeexperimental studyextracellular vesiclesimmune functionin vivoknock-downlymph nodeslymphatic vasculaturemelanomamultidimensional dataneoplastic cellnovelnovel therapeutic interventionpatient stratificationprotein transportskillssmall hairpin RNAsupport networktraining opportunitytumortumor growthtumor immunologyuptakevesicle transport
项目摘要
PROJECT SUMMARY
Tissues are primed for metastasis prior to the arrival of tumor cells. Primary tumors drive this transformation by
shedding tumor-derived factors (TDFs), including extracellular vesicles and secreted/shed proteins (TSPs) into
tumor-associated blood and lymphatic vasculature. Despite being the most common site of metastasis across
solid tumor types, we know very little about how the lymph node (LN) is primed for metastasis by TDFs. My
preliminary data demonstrates that primary melanomas initiate remodeling in their draining LNs that enhances
metastatic outgrowth relative to contralateral, non-draining and naïve LN controls. Furthermore, I have
demonstrated that TDFs uniquely activate this pro-metastatic LN phenotype rather than factors derived from
benign dermis or mouse albumin. The focus of this field has been on the role tumor-derived extracellular vesicles
play in establishing this pre-metastatic niche, however my data further demonstrates TSPs are also sufficient to
activate this niche. Using a novel cell-specific labeling strategy termed BONCAT (biorthogonal non-canonical
amino acid tagging), I have identified several candidate TSPs transported to the pre-metastatic LN. In this
proposal, I will test the hypothesis that TSPs initiate reprogramming events within resident cell populations of
the draining LN that support metastatic growth through two specific aims. The first aim will employ a scRNAseq
approach to identify cellular networks, TSP-induced crosstalk between the resident LN stroma and seeded tumor
cells, that provide trophic support to metastatic cells and the extent to which LN lymphangiogenesis is required
for LN metastasis. The second aim will investigate a specific TSP I have identified, CSPG4 (Melanoma-
Associated Chondroitin Sulfate Proteoglycan). This protein is shed by melanoma cells, has known melanoma
cell-intrinsic roles of invasion and is elevated in human melanoma patients, yet, it is unknown whether this TSP
contributes to pre-metastatic niche formation in distant sites. The completion of this work will provide foundational
information on TSP-dependent pre-metastatic niche development in the tdLN, and may uncover CSPG4 as a
novel driver of niche development. The proposed work will provide me with comprehensive training opportunities
integrating new bench techniques with high dimensional data analysis, ultimately preparing me for a modern
independent career as a researcher. Other training opportunities proposed will strengthen my professional skills
in writing, presenting, teaching/mentoring, and networking, laying the foundation for my long-term goals of
leading a research lab at an academic institution. My training objectives are supported by my sponsor (Dr.
Amanda Lund; Departments of Dermatology and Pathology) and co-sponsor (Dr. Itai Yanai; Departments of
Biochemistry and Molecular Pharmacology and Director of the Institute for Computational Medicine) who bring
expertise in cancer biology and immunology, and sequencing data analysis and integration, respectively.
项目摘要
在肿瘤细胞到达之前,组织已做好转移的准备。原发性肿瘤通过以下方式驱动这种转化:
脱落肿瘤衍生因子(TDFs),包括细胞外囊泡和分泌/脱落蛋白(TSP),
肿瘤相关的血液和淋巴管系统。尽管是最常见的转移部位,
虽然我们对实体瘤的类型知之甚少,但我们对淋巴结(LN)如何通过TDFs引发转移知之甚少。我
初步数据表明,原发性黑色素瘤在其引流淋巴结中启动重塑,
相对于对侧、非引流和初治LN对照的转移性生长。而且我也
表明TDFs独特地激活这种促转移LN表型,而不是来自于
良性真皮或小鼠白蛋白。这一领域的重点一直是肿瘤来源的细胞外囊泡的作用,
在建立这种转移前的生态位中发挥作用,然而,我的数据进一步表明TSP也足以
激活这个niche。使用一种新的细胞特异性标记策略,称为BONCAT(双正交非典型
氨基酸标记),我已经鉴定了几种转运到转移前LN的候选TSP。在这
在这个提议中,我将检验TSP在宿主细胞群中启动重编程事件的假设。
引流LN通过两个特定目的支持转移性生长。第一个目标将使用scRNAseq
识别细胞网络的方法,TSP诱导的驻留LN基质和接种肿瘤之间的串扰
细胞,为转移细胞提供营养支持,以及LN淋巴管生成所需的程度
淋巴结转移。第二个目标是研究我已经确定的一种特定的TSP,CSPG 4(黑色素瘤-黑色素瘤)。
相关硫酸软骨素蛋白聚糖)。这种蛋白质是由黑色素瘤细胞脱落的,
在人类黑色素瘤患者中,这种TSP在细胞内在的侵袭作用中升高,然而,目前尚不清楚这种TSP是否
有助于远处转移前的小生境形成。这项工作的完成将提供基础
tdLN中TSP依赖性转移前小生境发展的信息,并可能揭示CSPG 4作为一种转移因子。
利基发展的新驱动力。建议的工作将为我提供全面的培训机会
将新的工作台技术与高维数据分析相结合,最终为我准备了一个现代的
作为一名独立的研究员。建议的其他培训机会将加强我的专业技能
在写作,演示,教学/指导和网络,奠定了我的长期目标的基础,
领导一个学术机构的研究实验室。我的培训目标得到了我的赞助商(博士)的支持。
阿曼达隆德;皮肤科和病理科)和共同申办者(Itai柳井博士;
生物化学和分子药理学和计算医学研究所所长),
分别在癌症生物学和免疫学以及测序数据分析和整合方面拥有专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Haley du Bois其他文献
Haley du Bois的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Haley du Bois', 18)}}的其他基金
Lymph-Borne Melanoma-Derived Proteins as Determinants of Lymph Node Metastasis
淋巴源性黑色素瘤衍生蛋白作为淋巴结转移的决定因素
- 批准号:
10658869 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 3.9万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别: